Press release
Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impurity Standards
Icatibant, a selective bradykinin B2 receptor antagonist, is widely used in the treatment of hereditary angioedema (HAE). Given its peptide-based structure, Icatibant is prone to the formation of impurities during synthesis and storage. Accurate detection and quantification of these impurities are critical to ensuring drug safety, efficacy, and regulatory compliance.
"With growing regulatory demands for impurity profiling, access to high-quality impurity standards has become essential," said a spokesperson for Aquigen Bio. "Our Icatibant impurity standards are manufactured with precision and purity, enabling pharmaceutical companies and laboratories to achieve accurate analytical results and meet global compliance requirements."
Aquigen Bio's Icatibant Impurity Portfolio Includes:
https://aquigenbio.com/product/icatibant-impurity-5/
https://aquigenbio.com/product/icatibant-impurity-6/
https://aquigenbio.com/product/icatibant-impurity-7/
https://aquigenbio.com/product/icatibant-impurity-9/
These standards are widely used for:
Method development and validation
Stability and degradation studies
Regulatory submission support
Batch-to-batch consistency in pharmaceutical manufacturing
Aquigen Bio's Icatibant Impurity Standards are developed to meet stringent global quality benchmarks, offering high purity, reliability, and reproducibility in results.
Aquigen Bio Sciences
281/1, Plot No 41,
Hinjawadi - Pirangut Rd,
Kasar Amboli, Pirangut,
Pune, Maharashtra 412108
Visit: www.aquigenbio.com
Aquigen Bio is a leading provider of certified reference standards, impurity profiling compounds, and research chemicals to pharma, biotech, and academic institutions worldwide. With a dedication to excellence and a focus on regulatory readiness, Aquigen empowers scientists to innovate with confidence.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impurity Standards here
News-ID: 4154242 • Views: …
More Releases from Aquigen Bio Sciences
Elevating Analytical Precision with Harmine Impurity Standards
In the realm of pharmaceutical research, controlling the purity of compounds is pivotal. When evaluating psychoactive alkaloids such as harmine-a β-carboline alkaloid known for its reversible monoamine oxidase A inhibition and emerging therapeutic potential-accuracy is non-negotiable. This is where Aquigen Bio Sciences brings its edge: supplying high-grade impurity standards to underpin analytical consistency and regulatory compliance.
Why Harmine Impurity Standards Matter
https://aquigenbio.com/products/impurity-standards/harmine/
Harmine occurs naturally in Peganum harmala and Banisteriopsis caapi, and has…
AquigenBio Introduces High-Purity Daridorexant Hydrochloride to Support Sleep Di …
India - August 2025 - AquigenBio, a premier provider of pharmaceutical reference standards and impurity profiling solutions, proudly announces the release of Daridorexant Hydrochloride (CAS No. 1792993-84-0). This high-quality, precisely characterized compound is a hydrochloride salt form of Daridorexant, a dual orexin receptor antagonist with proven efficacy in the treatment of insomnia.
Explore Daridorexant Hydrochloride -
https://aquigenbio.com/product/daridorexant-hydrochloride/
The launch of this product marks a significant addition to AquigenBio's growing portfolio of sleep…
Riociguat N-Nitroso Des Formyl Impurity - Reliable Reference Standard for Advanc …
Riociguat N-Nitroso Des Formyl Impurity is a premium-quality analytical reference material developed to support research, testing, and quality control in the pharmaceutical industry.
As regulatory guidelines tighten worldwide, accurate detection, quantification, and control of nitroso impurities have become an essential part of drug development and manufacturing.
This compound plays a vital role in ensuring that formulations containing Riociguat meet the highest safety and compliance standards.
The Growing Importance of Nitroso Impurity…
Precision in Pharmaceutical Analysis: Resmetirom Impurity Standards from Aquigen …
Resmetirom is a breakthrough thyroid hormone receptor-β agonist, currently under investigation for the treatment of nonalcoholic steatohepatitis (NASH). The successful development, validation, and filing of Resmetirom-based therapies require precision in impurity profiling - a critical cornerstone of global regulatory acceptance.
Why Choose AquigenBio's Resmetirom Impurities?
1. High-Purity Reference Standards: Each impurity is synthesized and purified to >95% purity, with robust documentation including HPLC, MS, and NMR characterization data for your quality assurance.
2.…
More Releases for Icatibant
Peptide Based Hematological Disorders Therapeutics Market Set to Deliver Major R …
Peptide based haematological disorders therapeutics market is exhibiting robust growth. This is due to the fact that technology for the manufacturing of peptides is rapidly evolving, with manufacturers and suppliers exploring new methods for the manufacturing of peptides. This has a positive effect on the peptide therapeutics market and leads to the formation of longer and complex chain of peptides and reduced cost of production. In addition, due to the emergence…
Peptide Based Hematological Disorders Therapeutics Market Scenario Highlighting …
Peptide based haematological disorders therapeutics market is exhibiting robust growth. This is due to the fact that technology for the manufacturing of peptides is rapidly evolving, with manufacturers and suppliers exploring new methods for the manufacturing of peptides. This has a positive effect on the peptide therapeutics market and leads to the formation of longer and complex chain of peptides and reduced cost of production. In addition, due to the emergence…
Peptide Based Hematological Disorders Therapeutics Market Shares, Strategies and …
This Fact.MR report on the global peptide based hematological disorders therapeutics market forecasts that the global peptide based hematological disorders therapeutics market will touch a value of nearly US$ 530 Mn in the year 2022 and grow at a robust CAGR during the assessment period.
North America Market Set to Dominate the Global Peptide Based Hematological Disorders Therapeutics Market in Terms of Revenue
The market in North America is set to dominate…
Peptide Based Hematological Disorders Therapeutics Market Expected to Secure Not …
Due to the advances in technology, the manufacturers and suppliers are encouraged to seek novel methods for peptide manufacturing, which is bound to improve the production of longer and complex chain of peptides and reduce the cost of production. Moreover, due to the automation of instruments, with improvements in the purification process and reduction in the total waste generated, are the driving factors triggering the growth of the global peptide…
Global Peptide Based Hematological Disorders Therapeutics Market Expectations & …
FactMR research firm has recently updated its massive report catalogue by adding a fresh study titled “Peptide Based Hematological Disorders Therapeutics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022”. This business intelligence study encapsulates vital details about the market current as well as future status during the forecast period of 2017-2022 Readers can expect holistic and comprehensive analysis on the Peptide Based Hematological Disorders Therapeutics…
Angioedema Treatment Market Growth and Revenue Opportunities by Top Key Vendors …
Angioedema is the medical condition characterized by swelling of the lower layer of skin and tissue just under the skin or mucous membrane occurs. There are four main type of angioedema namely allergic angioedema, drug-induced angioedema, Idiopathic angioedema, and hereditary angioedema (HAE). Angioedema is caused by various factors and in most of the cases exact cause is unknown. Major cause of angioedema are allergic reaction, adverse effect of any medication,…
